Stay updated on RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial
Sign up to get notified when there's something new on the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page.

Latest updates to the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page
- Check3 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a software update to the page without altering trial details or user-facing content.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page footer now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a new build deployment of the site's frontend.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.6.3 has been added, replacing v3.6.2. This indicates a page version update rather than changes to the study data.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a newer version of the study record.SummaryDifference0.0%

- Check60 days agoChange DetectedNew navigation items and help sections were added to the Study Details page, including No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, and an Intervention/Treatment section, with the page revision labeled as v3.6.0. The label formatting for Intervention/Treatment was adjusted from the previous Interventions / Treatment.SummaryDifference0.3%

- Check68 days agoChange DetectedThe study record's revision tag updated from v3.5.4 to v3.5.5, indicating a minor update to the study documentation.SummaryDifference0.0%

Stay in the know with updates to RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RESPONDER-HF Trial Assessing Sacubitril/Valsartan in HF - Clinical Trial page.